Lamictal Pregnancy Monitoring Will Continue Following “FDA Alert”
This article was originally published in The Pink Sheet Daily
FDA issues leaflet to physicians and healthcare professionals regarding potential oral clefts in children exposed to Lamictal during first trimester of pregnancy.
You may also be interested in...
Next in the pipeline for GSK’s epilepsy franchise is an XR formulation for once-daily dosing.
The deputy commissioner reiterates that the agency has not become risk averse when it comes to approvals, however.
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.